# Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

> **NCT04949022** · NA · UNKNOWN · sponsor: **Helsinki University Central Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Medronic 780G insulin pump

## Key facts

- **NCT ID:** NCT04949022
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-23
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04949022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04949022, "Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04949022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*